Hilde Jensvoll
Eva Futtrup Maksten,
Lasse Hjort Jakobsen,
Boris Modrau,
Hilde Jensvoll,
Kristian Hay Kragholm,
Judit Mészáros Jørgensen
et al.:
Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study
Journal of Geriatric Oncology 2024 DOI
Emil Nyquist,
Jakob Dalgaard,
Signe Spetalen,
Synne Torkildsen,
Hege Frøen,
Eivind Galteland
et al.:
Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML
Hege S. Haugnes,
Helene Francisca Stigter Negaard,
Hilde Jensvoll,
Tom Wilsgaard,
Torgrim Tandstad,
Arne Solberg
:
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
Kristine Blix,
Olga Vikhammer Gran,
Marianne Tang Severinsen,
Suzanne C. Cannegieter,
Hilde Jensvoll,
Kim Overvad
et al.:
Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort
Journal of Thrombosis and Haemostasis 2018 DOI
Maria Averina,
Hilde Jensvoll,
Harald Strand,
Mikhail Sovershaev
:
A novel ANKRD26 gene variant causing inherited thrombocytopenia in a family of Finnish origin: Another brick in the wall?
Thrombosis Research 2017 DOI
Inger Lise Gade,
Sigrid Kufaas Brækkan,
Inger Anne Næss,
John-Bjarne Hansen,
Suzanne C. Cannegieter,
K Overvad
et al.:
The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort
Journal of Thrombosis and Haemostasis 2017 DOI
Inger Lise Gade,
Sigrid Kufaas Brækkan,
Inger Anne Næss,
John-Bjarne Hansen,
Frits Richard Rosendaal,
Suzanne C. Cannegieter
et al.:
Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort
Thrombosis Research 2017 DOI
Olga Vikhammer Gran,
Erin N. Smith,
Sigrid Kufaas Brækkan,
Hilde Jensvoll,
Terry Solomon,
Kristian Hindberg
et al.:
Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism
Hilde Jensvoll,
Marianne T. Severinsen,
Jens Hammerstrøm,
Sigrid Kufaas Brækkan,
Søren R. Kristensen,
Suzanne C. Cannegieter
et al.:
Existing data sources in clinical epidemiology: The Scandinavian Thrombosis and Cancer Cohort
Hilde Jensvoll,
Kristine Blix,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study
Kristine Blix,
Hilde Jensvoll,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism - The Tromso Study
Hilde Jensvoll,
Marie Falkenberg Smeland,
Heidi Tiller,
Øystein Lunde Holla,
Trine Prescott,
Anders Vik
:
En gravid kvinne med pancytopeni
Tidsskrift for Den norske legeforening (Tidsskriftet) 2019 DOI
Hilde Jensvoll,
Kristine Blix,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
Hematocrit measured prior to cancer development is not associated with future risk of venous thromboembolism in cancer patients - the Tromso Study
Thrombosis Research 2012 DOI
Hilde Jensvoll,
Kristine Blix,
Sigrid Kufaas Brækkan,
John-Bjarne Hansen
:
White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism in cancer patients' the Tromsø study
Thrombosis Research 2012 DOI
The 50 latest publications is shown on this page. See all publications in Cristin here →